About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Pilot Study Freeze and Transport Immune Cells | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT00138268

Pilot Study Freeze and Transport Immune Cells

To evaluate and standardize umbilical cord specimen collection and laboratory procedures to evaluate cellular and serological immune responses in neonates and young infants

Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID)•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

To evaluate: 1) The procedures for obtaining umbilical cord blood; 2) the methods for ensuring immune cell viability, freezing, and shipping; 3) the conditions for optimization of immune cell isolation procedures.

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•For the portion of the pilot study conducted at the UCLA CVR, an umbilical cord blood sample will be obtained from approximately 8 to 12 healthy pregnant women who are delivering neonates at the Obstetrical delivery ward of Harbor- UCLA Medical Center. Informed consent will not be obtained because the blood will be obtained after delivery from a clamped umbilical cord attached to the placenta (afterbirth) that otherwise would be discarded.

Exclusion Criteria

•A cord blood sample will not be collected from women who have requested special arrangements for a cord blood registry service.

Related studies

RECRUITINGPhase 2

A Study of Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver Fibrosis

NCT07417553 · Chronic Hepatitis B-related Liver Fibrosis

RECRUITINGPhase 2

Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection

NCT02932150 · Chronic Hepatitis B

RECRUITINGPhase 1

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection

NCT07024641 · Hepatitis B Virus Infection

RECRUITINGPhase 1

HepB mAb19 in Individuals With Chronic Hepatitis B Infection

NCT05856890 · Hepatitis b Virus, Hepatitis B

RECRUITINGPhase 1

Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B

NCT06671093 · Chronic Hep B, Chronic Hepatitis b, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 27, 2010Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment12

Start date—

Last updatedAug 27, 2010

Condition

Diphtheria Hepatitis B Pertussis Poliomyelitis Tetanus

Locations shown

UCLA Center For Vaccine Research

Torrance, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 27, 2010Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions